Lazarski Univeristy
Warsaw, 02-662, Poland
NCT Number: NCT04366297
The current COVID-19 pandemic, this is especially since the transmission of SARS-CoV-2 is thought to occur mainly through respiratory droplets generated by coughing and sneezing, by direct contact with contaminated surfaces and because in a large number of patients COVID-19 disease may be asymptomatic. As recommended by the CDC medical personnel should be equipped with full personal protective equipment (PPE) for AGP in contact with suspected/confirmed COVID-19 patient. Therefore, it is reasonable to search for the most effective methods of intravascular access in those conditions.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Warsaw, 02-662, Poland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
obtaining intravascular access using a standard intravenous cannula
Other names: IV
obtaining intravascular access using a ready intravenous NIO needle set
Other names: IO
Time frame: 1 day
successful placement of intravascular device
Time frame: 1 day
Time frame: 1 day
number of attempts to successful access
Time frame: 1 day
time to therapy including but not limited to time to fluids, antibiotics, and antiarrythmics
Time frame: 1 day
complication rates
Time frame: 1 day
self-reported percentage the vocal cord visualization. A 100% score is a extremely difficult procedure. A Ease of use score of 1% means that procedure is extremely easy
Time frame: 1 day
participants were asked which method of intravascular access they would prefer in a real-life resuscitation.
Lazarski University
Other
Intraosseous Versus Intravenous Access During COVID-19 Patients Performed by Paramedics Wearing Level C Personal Protective Equipment. A Multi-center Prospective Randomized Crossover Single-blinded Simulation Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02450071
Airway Obstruction, Brain Diseases
Gothenburg, VästraGötaland, Sweden
View Trial DetailsNCT01502111
Airway Obstruction, Cardiac Arrest
Drøbak, Norway
View Trial DetailsNCT04365608
COVID-19, Cardiac Arrest
Poznan, Poland
View Trial DetailsNCT04363788
COVID-19, Cardiac Arrest
Warsaw, Poland
View Trial Details